The California Institute for Regenerative Medicine in Emeryville, Calif., appointed new members to its scientific and medical research facilities working group. They are Albert Doms, Deborah Hysen, Edward Kashian, Sherry Lansing, David Lichtenger, Joan Samuelson, David Serrano Sewell, Jeff Sheehy and Janet Wright.

Neurogen Corp., of Branford, Conn., appointed Stephen Uden executive vice president, head of research and development.

NicOx SA, of Sophia-Antipolis, France, appointed Maarten Beekman vice president of clinical development, Ali Raza and Stefano Bionid director of the research laboratories, and promoted Ennio Ongini to vice president of research.

Novacea Inc., of South San Francisco, appointed Fong Wang Clow senior vice president of development, Charles Democko vice president of regulatory affairs, and promoted Paul Westberg to vice president of business development.

Oragenics Inc., of Alachua, Fla., appointed Robert Zahradnik acting president and CEO.

Oxxon Therapeutics Inc., of Boston, appointed Craig Smith to its board.

Pharmacopeia Drug Discovery Inc., of Princeton, N.J., appointed Michio Soga executive vice president and chief financial officer.

Pharming Group NV, of Leiden, the Netherlands, appointed John Pieters chief operating officer, and Sabine Hoekstra legal counsel.

Pharmos Corp., of Iselin, N.J., appointed Abraham Sartani to its board.

Pozen Inc., of Chapel Hill, N.C., appointed William Kelce vice president, preclinical development.

Questcor Pharmaceuticals Inc., of Union City, Calif., appointed Gregg Lapointe to its board.

Revance Therapeutics, of Mountain View, Calif., appointed Mary Spellman senior vice president of clinical development, Jane Moffitt senior vice president of regulatory affairs, and Bobby Purkait senior vice president of R&D and operations.

Sirna Therapeutics Inc., of San Francisco, appointed Michael French senior vice president for corporate development.

Spectranetics Corp., of Colorado Springs, Colo., appointed Kelly Elliott vice president of clinical affairs.

Spectrum Pharmaceuticals Inc., of Irvine, Calif., appointed Chuck Chukwumerije vice president, quality assurance and quality control.

Symphogen A/S, of Copenhagen, Denmark, appointed Paul Rohricht vice president of business development.

Tanox Inc., of Houston, appointed Julia Brown to its board.

No Comments